A new program from the Digital Therapeutics Alliance and DirectTrust is betting yes. Healthcare’s acceptance of digital therapeutics (DTx) continues to be a long and winding road. Two organizations ...

Orion Corporation (“Orion”) and Newel Health (“Newel”) have entered into a license agreement regarding ODD-403 (“Rohkea”), a digital therapeutic (DTx) developed by Orion for patients suffering from ...

AlcoChange DTx, an MHRA-cleared, UKCA Class-IIa marked digital therapeutic for ArLD, delivers a proprietary, evidence-based behavioural therapy framework to manage cravings, support abstinence or ...

4 insights from one digital therapeutics startup. Despite a startup’s unique ability to launch not only its product but its business model from the ground up, many spend years learning the same lesson ...

The Digital Therapeutics Alliance's annual conference kicked off Wednesday in Washington, D.C. The conference aims to bring together providers, payers, companies and regulatory agencies to discuss the ...

DirectTrust and the Digital Therapeutics Alliance announced this week that they'll work together on an accreditation program designed to test the efficacy and security of digital-therapeutic apps and ...

It’s been two years since the first software-only digital therapeutic got the FDA greenlight, but the industry is still very much in its infancy and continuing to evolve. New entrances are emerging ...

Big Health, a maker of digital treatments for mental health, has clinched Food & Drug Administration (FDA) clearance of its product for insomnia, Fierce Healthcare has learned in an advanced look.

Digital healths’ moment in the sun doesn’t appear to be ending anytime soon, and one area that is just beginning its journey into virtual care is the pharmaceutical industry. In recent years, pharma ...